Citizens Initiates Coverage On Biomea Fusion with Market Outperform Rating, Announces Price Target of $9
Benzinga Newsdesk 6 months ago
NewsPrice TargetInitiationAnalyst Ratings
Citizens analyst Jonathan Wolleben initiates coverage on Biomea Fusion (NASDAQ:BMEA) with a Market Outperform rating and announces Price Target of $9.
Citizens analyst Jonathan Wolleben initiates coverage on Biomea Fusion (NASDAQ:BMEA) with a Market Outperform rating and announces Price Target of $9.